A Next Generation Immunotherapy for Human Papilloma Virus induced Cervical Cancer

Project Information

IMMUNISA

Grant agreement ID: 731623

DOI 10.3030/731623

Project terminated on 20 August 2019

EC signature date 21 November 2017

Start date 1 December 2017

End date 30 November 2022

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost € 5 999 999,50

EU contribution € 5 999 999,50

Coordinated by

KATHOLIEKE UNIVERSITEIT LEUVEN
Belgium